{"transactions":[{"id":677956,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-24T17:20:13.000Z","date":"2026-08-21","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.65,"value":13000.0,"ownership":{"direct":true},"balance_after":73533,"source":{"system":"sec-edgar","filing":"0001493152-26-039816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226039816/ownership.xml","form_type":"4"}},{"id":680480,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-21T00:20:26.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":16634,"price":0.5898,"value":9810.7332,"ownership":{"direct":true},"balance_after":53533,"source":{"system":"sec-edgar","filing":"0001493152-26-039537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226039537/ownership.xml","form_type":"4"}},{"id":680479,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-20T13:23:56.000Z","date":"2026-08-19","kind":"purchase","planned":false,"acquired":true,"shares":2700,"price":0.35,"value":945.0,"ownership":{"direct":true},"balance_after":36899,"source":{"system":"sec-edgar","filing":"0001493152-26-039399","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226039399/ownership.xml","form_type":"4"}},{"id":689834,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-12T22:51:58.000Z","date":"2026-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2220,"price":0.32,"value":710.4,"ownership":{"direct":true},"balance_after":34199,"source":{"system":"sec-edgar","filing":"0001493152-26-037468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226037468/ownership.xml","form_type":"4"}},{"id":692329,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-10T14:17:28.000Z","date":"2026-08-06","kind":"purchase","planned":false,"acquired":true,"shares":685,"price":0.22,"value":150.7,"ownership":{"direct":true},"balance_after":31979,"source":{"system":"sec-edgar","filing":"0001493152-26-036782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226036782/ownership.xml","form_type":"4"}},{"id":694627,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF"}}],"security":"COMMON STOCK","published_at":"2026-08-07T00:29:33.000Z","date":"2026-08-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.2588,"value":1294.0,"ownership":{"direct":true},"balance_after":31294,"source":{"system":"sec-edgar","filing":"0001493152-26-036442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226036442/ownership.xml","form_type":"4"}},{"id":699287,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. CHAIR & PRINCIPAL OFF."}}],"security":"COMMON STOCK","published_at":"2026-08-03T21:29:31.000Z","date":"2026-07-30","kind":"purchase","planned":false,"acquired":true,"shares":26291,"price":0.1828,"value":4805.9948,"ownership":{"direct":true},"balance_after":26291,"source":{"system":"sec-edgar","filing":"0001493152-26-035868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315226035868/ownership.xml","form_type":"4"}},{"id":1556845,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92486,"kind":"person","name":"WRIGHT TIMOTHY R","position":1,"cik":"0001288245","reported_name":"WRIGHT TIMOTHY R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-04-02T01:41:26.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":1.74,"value":36975.0,"ownership":{"direct":true},"balance_after":21250,"derivative":{"exercise_price":1.74,"exercise_date":"2026-03-25","expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001493152-24-012598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012598/ownership.xml","form_type":"4"}},{"id":1557782,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:23.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":1.74,"value":130500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable."}],"balance_after":75000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-012073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012073/ownership.xml","form_type":"4"}},{"id":1557774,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:19.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":1.74,"value":39150.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":1.74,"exercise_date":"2026-03-25","expiration_date":"2034-03-25","underlying":"PTIX common stock, Par Value $0.0001","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001493152-24-012070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012070/ownership.xml","form_type":"4"}},{"id":1557775,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:15.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":1.74,"value":130500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable."}],"balance_after":75000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-012071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012071/ownership.xml","form_type":"4"}},{"id":1557796,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:14.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":1.74,"value":435000.0,"ownership":{"direct":true},"balance_after":250000,"derivative":{"exercise_price":1.74,"exercise_date":"2027-03-25","expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-24-012068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315224012068/ownership.xml","form_type":"4"}},{"id":1557773,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:10.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":43750,"price":1.74,"value":76125.0,"ownership":{"direct":true},"balance_after":43750,"derivative":{"exercise_price":1.74,"exercise_date":"2026-03-25","expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001493152-24-012072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012072/ownership.xml","form_type":"4"}},{"id":1557771,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:07.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":1.74,"value":174000.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":1.74,"exercise_date":"2027-03-25","expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-012069","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012069/ownership.xml","form_type":"4"}},{"id":1760737,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2023-10-13T16:48:45.000Z","date":"2023-10-12","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":0.81,"value":6480.0,"ownership":{"direct":true},"balance_after":45815,"source":{"system":"sec-edgar","filing":"0001493152-23-037136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315223037136/ownership.xml","form_type":"4"}},{"id":2266322,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2022-05-18T21:11:21.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":8000,"price":0.72,"value":5760.0,"ownership":{"direct":true},"balance_after":151260,"source":{"system":"sec-edgar","filing":"0001493152-22-014338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315222014338/ownership.xml","form_type":"4"}},{"id":2266321,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2022-05-18T21:11:21.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":23000,"price":0.71,"value":16330.0,"ownership":{"direct":true},"balance_after":143260,"source":{"system":"sec-edgar","filing":"0001493152-22-014338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315222014338/ownership.xml","form_type":"4"}},{"id":2684261,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-03T22:13:18.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":16900,"price":0.38,"value":6422.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-06-03","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":16900},"source":{"system":"sec-edgar","filing":"0001493152-21-013554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013554/ownership.xml","form_type":"4"}},{"id":2684260,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-03T22:13:18.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":100,"price":0.38,"value":38.0,"ownership":{"direct":true},"balance_after":33100,"derivative":{"exercise_price":4.98,"exercise_date":"2021-06-02","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001493152-21-013554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013554/ownership.xml","form_type":"4"}},{"id":2689658,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock NSO Options","published_at":"2021-06-01T22:54:37.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price was determined by the Board of Directors at a Board Meeting held May 26, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021."}],"balance_after":180000,"derivative":{"exercise_price":3.65,"expiration_date":"2031-05-26","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001493152-21-013384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013384/ownership.xml","form_type":"4"}},{"id":2689654,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-01T10:05:16.000Z","date":"2021-05-27","kind":"purchase","acquired":true,"shares":3000,"price":0.38,"value":1140.0,"ownership":{"direct":true},"balance_after":33000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-27","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001493152-21-013279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013279/ownership.xml","form_type":"4"}},{"id":2703818,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-05-20T20:24:03.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":18000,"price":0.31,"value":5580.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-18","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001493152-21-012357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221012357/ownership.xml","form_type":"4"}},{"id":2703817,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-05-20T20:24:03.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":12000,"price":0.32,"value":3840.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-18","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001493152-21-012357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221012357/ownership.xml","form_type":"4"}},{"id":2727987,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2030-02-13","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727986,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":120000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727985,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":165000,"derivative":{"exercise_price":1.25,"expiration_date":"2027-01-01","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727984,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are fully vested."}],"balance_after":315000,"derivative":{"exercise_price":1.25,"expiration_date":"2026-04-15","underlying":"PTIX common stock, Par Value $0.000001","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727983,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":120000,"price":1.75,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":410000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727982,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":45000,"price":1.75,"value":78750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":290000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727981,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":150000,"price":1.25,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":245000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2727980,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Protagenic Therapeutics, Inc. Common Stock","published_at":"2021-05-05T10:10:19.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":45000,"price":1.25,"value":56250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001493152-21-010465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010465/ownership.xml","form_type":"4"}},{"id":2733404,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2021-05-03T20:15:08.000Z","date":"2021-04-30","kind":"purchase","acquired":true,"shares":1000,"price":2.29,"value":2290.0,"ownership":{"direct":true},"balance_after":120260,"source":{"system":"sec-edgar","filing":"0001493152-21-010335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010335/ownership.xml","form_type":"4"}},{"id":2733403,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2021-05-03T20:15:08.000Z","date":"2021-04-29","kind":"purchase","acquired":true,"shares":1000,"price":2.29,"value":2290.0,"ownership":{"direct":true},"balance_after":119260,"source":{"system":"sec-edgar","filing":"0001493152-21-010335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010335/ownership.xml","form_type":"4"}},{"id":3079124,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-07-21T21:06:47.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":145000,"price":1.75,"value":253750.0,"ownership":{"direct":true},"balance_after":145000,"derivative":{"exercise_price":1.75,"exercise_date":"2020-07-18","expiration_date":"2030-07-18","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001493152-20-013713","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220013713/ownership.xml","form_type":"4"}},{"id":3079125,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2020-07-21T21:05:52.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":124998,"price":1.75,"value":218746.5,"ownership":{"direct":true},"balance_after":124998,"derivative":{"exercise_price":1.75,"exercise_date":"2020-07-18","expiration_date":"2030-07-18","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":124998},"source":{"system":"sec-edgar","filing":"0001493152-20-013712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220013712/ownership.xml","form_type":"4"}},{"id":3246918,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:32:16.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As this was an option grant, there was no cost to the recipient."}],"balance_after":150000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-20-003043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003043/ownership.xml","form_type":"4"}},{"id":3246916,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:29:04.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX common stock, Par Value $0.0001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-003041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003041/ownership.xml","form_type":"4"}},{"id":3246917,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:26:00.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-003039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003039/ownership.xml","form_type":"4"}},{"id":3247096,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:21:45.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":1.75,"exercise_date":"2023-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-20-003037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315220003037/ownership.xml","form_type":"4"}},{"id":3246914,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:18:38.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As this was an option grant, there was no cost to the recipient."}],"balance_after":120000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-20-003035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003035/ownership.xml","form_type":"4"}},{"id":3246915,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:15:14.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":307497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As this was an option grant, there was no cost to the recipient."}],"balance_after":307497,"derivative":{"exercise_price":1.75,"exercise_date":"2023-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":307497},"source":{"system":"sec-edgar","filing":"0001493152-20-003033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003033/ownership.xml","form_type":"4"}},{"id":3253892,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2020-02-24T19:16:10.000Z","date":"2019-11-05","kind":"purchase","acquired":true,"price":50000,"reported_value":50000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share."}],"derivative":{"exercise_price":1.25,"exercise_date":"2019-11-05","expiration_date":"2023-11-06","underlying":"Common stock, par value $0.0001 per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-20-002881","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220002881/ownership.xml","form_type":"5"}},{"id":3254338,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Convertible Note","published_at":"2020-02-24T19:12:30.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"price":200000,"reported_value":200000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share."}],"derivative":{"exercise_price":1.25,"exercise_date":"2019-11-20","expiration_date":"2023-11-06","underlying":"Common stock, par value $0.0001 per share","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-20-002879","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000149315220002879/ownership.xml","form_type":"5"}},{"id":3580130,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2019-03-25T10:10:16.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41667,"derivative":{"exercise_price":1,"exercise_date":"2019-03-31","expiration_date":"2029-03-20","underlying":"PTIX","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-19-003805","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315219003805/ownership.xml","form_type":"4"}},{"id":4184194,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T21:34:15.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":95000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001437749-17-017263","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017263/rdgdoc.xml","form_type":"4"}},{"id":4184193,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:46:57.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 36 months, full vesting upon change of control"}],"balance_after":75000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-17-017238","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017238/rdgdoc.xml","form_type":"4"}},{"id":4184222,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":20548,"kind":"person","name":"ARMEN GARO H","position":1,"cik":"0000935679","reported_name":"ARMEN GARO H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Executive Chairman"}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:42:35.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 36 months, full vesting upon change of control"}],"balance_after":250000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-17-017237","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/935679/000143774917017237/rdgdoc.xml","form_type":"4"}},{"id":4184192,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy()","published_at":"2017-10-18T18:23:30.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":200000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-17-017235","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017235/rdgdoc.xml","form_type":"4"}},{"id":4184190,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:18:46.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":45000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-17-017234","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017234/rdgdoc.xml","form_type":"4"}},{"id":4184191,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92545,"kind":"person","name":"Barrage Khalil","position":1,"cik":"0001666011","reported_name":"Barrage Khalil","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:13:26.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":45000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-17-017233","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017233/rdgdoc.xml","form_type":"4"}}]}